Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2008-06-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Treatment on Decision-making in Major Depression
NCT01916824
Making Decisions About Depression Medications
NCT01502891
Depression Medication Choice Decision Aid
NCT03887390
Action Tendencies and Prognosis in Major Depressive Disorder
NCT04593537
Assessing Change in Short Term Therapy for Depression
NCT02134678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will also evaluate three other potential indicators of treatment response: cortisol, cytokines, and grip strength.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment-as-usual
All patients will receive treatment as usual: antidepressant medication and/or cognitive behavioral therapy (CBT). Patients' results will be compare to their own baseline measurements.
Treatment-as-usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment-as-usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Depression not currently effectively treated
* Age 19 to 65 years
Exclusion Criteria
19 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diane McIntosh, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copeman Neuroscience Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D1443L00014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.